Some HCPs provided very general advice on how to counteract common side-effects, such as loss of bone mineral density.HCP(M)16: And I think for those of us who are initiating certainly aromatase inhibitors, we will of necessity warn them of the risk of osteoporosis... Here, CYP19A1 is linked to osteoporosis.